Open
SectorHealthcare
37.29 1.25
24h
Min
36.28
Max
37.29
Income | -18M -151M |
---|---|
Sales | -26M 139M |
EPS | -1.57 |
Profit margin | -108.463 |
Employees | 1,294 |
EBITDA | -18M -126M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +138.07% upside |
Next Earnings | 31 Jul 2025 |
---|
Market Cap | -209M 3.4B |
---|---|
Previous open | 36.04 |
Previous close | 37.29 |
By Acuity
34%
66%
99 / 380 Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 87.87 USD 138.07%
High 136 USD
Low 39 USD
Based on 15 Wall Street analysts offering 12 month price targets forUltragenyx Pharmaceutical Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$